Thank you to our members who cast their vote during the 2023 Annual General Meeting

HAE Canada, along with 12 other rare disease patient organizations, and Takeda Canada, unite to

Institut national d'excellence en santé et services sociaux (INESSS), whose missions is "to promote clinical

Qualifying HAE patients who access treatments through Veterans Affairs Canada (VAC) now have access to

Great news for eligible HAE patients in PEI. Lanadelumab (TAKHZYRO), a subcutaneous injection to routinely

On March 22, 2023, the Canadian federal government announced their plan to provide up to

We are thrilled to share that the Canadian Agency for Drugs and Technologies in Heath

To honour Rare Disease Day 2023, HAE Canada President, and Ontario Regional Director, Michelle Cooper,

For Canada's Rare Voices 2023, Patient Voice teamed up with 12 patients and their families,

We have some announcements to make about the HAE Canada Board of Directors. The 2022-2023